VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
ZTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ZTSZoetis Inc.
$72.97$30.6B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksZTSBalance Sheet

Zoetis Inc. (ZTS) Balance Sheet

16Y historyFree accessUpdated daily

Debt-to-equity collapsed from 2.86 in 2026Q1 to 0.06 in 2026Q2 following a $9B debt repayment, while current ratio improved to 3.08, signaling a robust liquidity position.

ZTS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Total Current Assets6.36B6.77B5.99B6.34B7.51B6.93B6.61B4.75B4.4B4.22B3.39B3.83B3.46B3.36B2.86B2.31B2.12B
Cash & Short-Term Investments1.68B2.31B1.99B2.04B3.58B3.48B3.6B1.93B1.7B1.56B727M1.15B882M610M317M79M63M
Cash Only1.48B2.31B1.99B2.04B3.58B3.48B3.6B1.93B1.6B1.56B727M1.15B882M610M317M79M63M
Short-Term Investments200M000000099M00000000
Accounts Receivable1.57B1.59B1.32B1.3B1.22B1.13B1.01B1.09B1.04B998M913M937M980M1.14B900M871M773M
Days Sales Outstanding59.5261.351.955.7154.8953.1855.3963.3264.9268.6468.1871.7774.7591.0775.7675.178.77
Inventory2.57B2.43B2.31B2.56B2.35B1.92B1.63B1.41B1.39B1.43B1.5B1.47B1.29B1.29B1.34B1.06B995M
Days Inventory Outstanding329.81317.45294.3345.34328.7284.86268.03239.71250.35279.43314.17297.81264.76273.12303.6228.91242.6
Other Current Assets535M436M379M436M369M392M368M320M276M228M248M272M314M316M302M298M285M
Total Non-Current Assets8.72B8.7B8.25B7.94B7.42B6.97B7B6.8B6.38B4.37B4.26B4.08B3.12B3.2B3.4B3.4B3.17B
Property, Plant & Equipment4.03B3.97B3.61B3.43B2.97B2.6B2.39B2.13B1.66B1.44B1.38B1.31B1.32B1.29B1.24B1.24B1.15B
Fixed Asset Turnover2.40x2.39x2.56x2.49x2.72x2.99x2.79x2.94x3.51x3.70x3.54x3.65x3.63x3.52x3.49x3.41x3.12x
Goodwill2.77B2.77B2.72B2.76B2.75B2.68B2.69B2.59B2.52B1.51B1.48B1.46B976M982M985M989M934M
Intangible Assets918M998M1.13B1.34B1.38B1.47B1.71B1.89B2.05B1.27B1.23B1.19B727M803M868M928M924M
Long-Term Investments1M030M00000000000000
Other Non-Current Assets384M328M220M206M147M111M106M98M94M75M73M49M48M58M88M97M92M
Total Assets15.08B15.47B14.24B14.29B14.93B13.9B13.61B11.54B10.78B8.59B7.65B7.91B6.59B6.56B6.26B5.71B5.28B
Asset Turnover0.63x0.61x0.65x0.60x0.54x0.56x0.49x0.54x0.54x0.62x0.64x0.60x0.73x0.70x0.69x0.74x0.68x
Asset Growth %25.85%8.64%-0.34%-4.28%7.37%2.14%17.88%7.13%25.52%12.25%-3.34%20.11%0.46%4.73%9.65%8.08%-
Total Current Liabilities2.06B2.23B3.41B1.89B3.17B1.8B2.17B1.81B1.22B1.09B1.12B1.78B1.09B1.42B1.12B843M808M
Accounts Payable452M487M433M411M405M436M457M301M313M261M265M293M290M506M319M214M206M
Days Payables Outstanding61.163.6255.2655.3656.7764.5975.2451.1756.3351.1155.4359.4859.57106.8872.0146.0850.23
Short-Term Debt053M1.35B3M1.35B0604M500M9M00405M7M15M73M038M
Deferred Revenue (Current)23M11M000000000000000
Other Current Liabilities2.06B895M566M484M397M459M388M331M300M280M265M297M246M248M701M611M540M
Current Ratio3.08x3.03x1.75x3.36x2.37x3.86x3.05x2.63x3.60x3.85x3.03x2.15x3.19x2.37x2.55x2.74x2.62x
Quick Ratio1.84x1.94x1.08x2.00x1.63x2.79x2.30x1.85x2.46x2.55x1.69x1.33x2.00x1.46x1.35x1.48x1.39x
Cash Conversion Cycle328.24315.13290.93345.69326.81273.46248.18251.86258.94296.96326.92310.1279.95257.31307.36257.93271.14
Total Non-Current Liabilities9.87B9.9B6.05B7.41B7.36B7.56B7.67B7.03B7.37B5.71B5.03B5.04B4.17B4.18B1.1B1.13B1.13B
Long-Term Debt190M9.24B5.22B6.56B6.55B6.59B6.59B5.95B6.44B4.95B4.47B4.46B3.62B3.64B509M575M673M
Capital Lease Obligations599M202M174M188M186M151M163M164M000000000
Deferred Tax Liabilities538M139M167M146M142M320M378M434M474M380M244M264M277M322M323M311M218M
Other Non-Current Liabilities9.56B305M494M508M475M496M530M486M452M373M321M314M264M217M266M246M241M
Total Liabilities11.93B12.14B9.47B9.29B10.52B9.36B9.84B8.84B8.59B6.8B6.15B6.82B5.25B5.6B2.22B1.98B1.94B
Total Debt190M9.49B6.74B6.75B8.09B6.74B7.36B6.61B6.45B4.95B4.47B4.87B3.63B3.66B582M575M711M
Net Debt-1.29B7.18B4.76B4.72B4.51B3.26B3.76B4.68B4.86B3.39B3.74B3.71B2.75B3.05B265M496M648M
Debt / Equity0.06x2.85x1.41x1.35x1.84x1.48x1.95x2.44x2.95x2.77x2.98x4.46x2.72x3.80x0.14x0.15x0.21x
Debt / EBITDA0.05x2.32x1.73x1.90x2.38x2.07x2.72x2.72x2.95x2.52x2.72x4.26x3.53x4.15x0.55x0.65x1.44x
Net Debt / EBITDA-0.33x1.76x1.22x1.32x1.33x1.00x1.39x1.93x2.22x1.72x2.28x3.25x2.67x3.46x0.25x0.56x1.31x
Interest Coverage14.39x14.74x13.95x12.38x12.21x11.54x9.02x8.44x8.97x9.71x8.40x5.40x8.01x7.09x23.90x11.94x5.81x
Total Equity3.15B3.33B4.77B4.99B4.4B4.54B3.77B2.71B2.19B1.79B1.5B1.09B1.34B962M4.04B3.74B3.34B
Equity Growth %-94.33%-30.17%-4.43%13.35%-3.1%20.43%39.33%23.94%22.34%19.15%37.4%-18.4%38.98%-76.19%8.16%11.72%-
Book Value per Share7.547.5110.4910.809.369.537.885.624.493.623.012.172.661.928.087.756.94
Total Shareholders' Equity3.15B3.33B4.77B5B4.41B4.54B3.77B2.71B2.19B1.77B1.49B1.07B1.31B940M4.03B3.72B3.34B
Common Stock5M5M5M5M5M5M5M5M5M5M5M5M5M5M000
Retained Earnings14.65B13.74B11.97B10.29B8.67B7.19B5.66B4.43B3.27B2.11B1.48B876M709M276M000
Treasury Stock0-10.69B-7.45B-5.6B-4.54B-2.95B-2.23B-2.04B-1.49B-852M-421M-203M00000
Accumulated OCI-796M-834M-940M-839M-817M-764M-730M-726M-629M-505M-598M-622M-361M-219M-157M-65M-74M
Minority Interest000-6M-2M1M4M0016M12M23M26M22M15M16M0

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Debt refinancing and revenue stagnation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strength Amidst Debt Shift

Zoetis' total assets have grown modestly from $14.3B to $15.1B over the past year, while equity dropped sharply in 2026Q2 due to a $9B debt repayment, as per SEC filings.

The balance sheet appears to be transitioning from a leveraged structure to a more conservative one, with total debt plummeting from $9.2B in 2026Q1 to $190M in 2026Q2. This dramatic deleveraging, likely funded by cash and operating cash flows, strengthens the equity base but also reduces financial flexibility. The shift suggests management is prioritizing balance sheet resilience, though the sudden change warrants monitoring for any associated one-time charges or asset sales.

Leverage Collapse Signals Strategic Shift

Debt-to-equity ratio fell from 2.86 in 2026Q1 to 0.06 in 2026Q2, as reported in financial statements, indicating a near-complete elimination of debt, a dramatic strategic pivot.

The near-total debt repayment in 2026Q2 appears to be a deliberate deleveraging event, possibly funded by cash reserves and strong operating cash flow. This reduces interest expense and refinancing risk, but also suggests that the company may have had excess cash or sold assets. Investors should monitor whether this is a one-time event or a new capital structure policy, as the previous leverage levels were consistent with a mature, cash-generative business.

Asset Mix Stable with Growing PPE

PPE net increased from $3.5B to $4.0B over the past year, while goodwill remained flat at $2.8B, as per SEC filings, indicating ongoing investment in tangible assets.

The steady increase in PPE suggests continued capital expenditure in manufacturing or facilities, aligning with the company's industrial nature. Goodwill stability implies no major acquisitions or impairments, which is positive for asset quality. The asset mix remains heavily weighted toward tangible assets, which may provide collateral value but also indicates a capital-intensive business model.

Equity Base Compressed by Buybacks

Retained earnings grew to $14.7B in 2026Q2, but total equity fell to $3.1B from $5.1B a year earlier, as reported in financial statements, reflecting aggressive share repurchases.

The decline in equity despite rising retained earnings is a clear sign of substantial share buybacks, which reduce the equity base. This capital allocation strategy boosts EPS but increases financial leverage if debt is used. However, with debt now minimal, the low equity is not a concern for solvency, but it does indicate a preference for returning capital over building a larger equity cushion.

Liquidity Buffer Remains Robust

Current ratio improved to 3.08 in 2026Q2 from 1.75 in 2024Q4, with cash at $1.5B, as per financial statements, indicating ample short-term liquidity.

The current ratio has consistently remained above 1.7, and the spike to 3.08 in 2026Q2 suggests a strong liquidity position, even after the debt repayment. Cash levels, while lower than the prior quarter, are still substantial relative to current liabilities. This provides a solid buffer against operational shocks and supports ongoing dividend and buyback programs.

Debt Repayment May Mask Underlying Stagnation

The dramatic deleveraging in 2026Q2, with debt falling to $190M, may be a one-time event that obscures stagnant revenue growth, as per SEC filings, warranting scrutiny of core operations.

While the balance sheet appears healthier, the sudden debt repayment could be financed by asset sales or a strategic shift that may not be sustainable. The lack of deferred revenue and minimal growth in assets suggests limited forward visibility. Investors should question whether the deleveraging is a sign of strength or a response to operational challenges, especially given the prior income statement analysis showing revenue growth of only 0.3%.

ZTS — Frequently Asked Questions

Quick answers to the most common questions about buying ZTS stock.

What are the total assets of Zoetis Inc. (ZTS)?

As of 2025, Zoetis Inc. (ZTS) had total assets of $15.47B including $6.77B in current assets.

How much debt does Zoetis Inc. (ZTS) have?

Zoetis Inc. (ZTS) carries total debt of $9.49B, offset by $2.31B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Zoetis Inc.?

Zoetis Inc. (ZTS) has total shareholders' equity (book value) of $3.33B ($7.51 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Zoetis Inc.'s current ratio and liquidity?

Zoetis Inc. (ZTS) reported a current ratio of 3.03x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.